Adage Capital Partners
EXAS

Adage Capital Partners’s Exact Sciences EXAS Stock Holding History

Adage Capital Partners’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,067,342
Closed -$108M – 1002
2025
Q4 		$108M Buy
+1,067,342
New +$85.7M 0.16% 118
2025
Q1 		– Sell
-378,200
Closed -$21.3M – 877
2024
Q4 		$21.3M Buy
+378,200
New +$23.5M 0.04% 432
2024
Q2 		– Sell
-18,200
Closed -$1.26M – 893
2024
Q1 		$1.26M Sell
18,200
-110,000
-86% -$6.96M ﹤0.01% 784
2023
Q4 		$9.48M Sell
128,200
-6,800
-5% -$446K 0.02% 602
2023
Q3 		$9.21M Buy
+135,000
New +$11.5M 0.02% 578
2019
Q2 		– Sell
-50,000
Closed -$4.33M – 725
2019
Q1 		$4.33M Sell
50,000
-61,000
-55% -$5.19M 0.01% 615
2018
Q4 		$7M Buy
111,000
+11,000
+11% +$755K 0.02% 562
2018
Q3 		$7.89M Buy
+100,000
New +$6.52M 0.02% 579
2016
Q3 		– Sell
-300,000
Closed -$3.67M – 701
2016
Q2 		$3.67M Buy
+300,000
New +$2.26M 0.01% 613

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Adage Capital Partners's EXAS Position: Q1 2026 in Review

Adage Capital Partners sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,067,342 shares — an estimated $108M sold.

Adage Capital Partners first reported a position in EXAS in Q2 2016 and held it in 9 quarters. The position peaked at $108M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Adage Capital Partners reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Adage Capital Partners sold 1,067,342 Exact Sciences shares in Q1 2026, an estimated $108M.
  • Adage Capital Partners first reported a position in Exact Sciences in Q2 2016 and held it in 9 quarters.
  • Adage Capital Partners's Exact Sciences position peaked at $108M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.